Cyst sclerotherapy with minocycline hydrochloride in patients with autosomal dominant polycystic kidney disease

Nephrol Dial Transplant. 1996 May;11(5):843-6. doi: 10.1093/oxfordjournals.ndt.a027410.

Abstract

Background: The enlarged cysts in autosomal dominant polycystic kidney disease (ADPKD) frequently cause abdominal discomfort. Cyst sclerotherapy with minocycline hydrochloride was performed to relieve this symptom.

Methods: Ten symptomatic ADPKD cases were recruited. As a sclerosant, minocycline hydrochloride solution (10 mg/dl) was used. This solution was instilled into the cysts under ultrasonographic control. Renal volume was calculated before therapy and at 6-month intervals thereafter. Renal function and blood pressure were regularly monitored. The effect of sclerotherapy on symptoms was also assessed at 6-month intervals.

Results: At 6 months, renal volume was statistically lower than the presclerotherapy, and was associated with improvement in chronic symptoms. However, such ameliorating effects were blunted at 12 months. Renal volume reduction at 6 and 12 months showed a significant positive correlation with the dose of minocycline injected. No significant influence in renal function and blood pressure was observed.

Conclusions: These results suggest that cyst sclerotherapy with minocycline hydrochloride is a valid treatment regime for the relief of chronic symptoms in ADPKD cases, although repeated application of this approach may be required to obtain a more long-term effect.

MeSH terms

  • Adult
  • Aged
  • Evaluation Studies as Topic
  • Female
  • Humans
  • Kidney / pathology
  • Male
  • Middle Aged
  • Minocycline / administration & dosage*
  • Polycystic Kidney, Autosomal Dominant / diagnostic imaging
  • Polycystic Kidney, Autosomal Dominant / pathology
  • Polycystic Kidney, Autosomal Dominant / therapy*
  • Sclerotherapy / methods*
  • Tomography, X-Ray Computed

Substances

  • Minocycline